Urotronic
Latest round
- Series B
Last raised
- Aug 2018
Total raised
- $20M
Investors
- 4
About Urotronic
Based in Minnesota, US, and founded in 2015, Urotronic, Inc. operates as a medical device company that develops a drug-coated balloon (DCB) called Optilume used for the treatment and prevention of recurrence of urethral stricture. from CD Capital, Hillhouse Capital Group, Legend Capital, and Mayo Clinic Ventures. Urotronic provides optilume, which is a urethral drug-coated balloon used as an alternative to endoscopic stricture treatments for male anterior urethral strictures that offers immediate relief.
Who invested in Urotronic
4 investors across 1 round
See all investors in Urotronic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 20, 2018
Amount
$20M
Investors
Questions about Urotronic
Who invested in Urotronic?
Urotronic has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Urotronic raised?
Urotronic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Urotronic last raise money?
Urotronic's most recent round on record is a Series B, in Aug 2018.
What does Urotronic do?
Based in Minnesota, US, and founded in 2015, Urotronic, Inc.
Where is Urotronic headquartered?
Urotronic is headquartered in Plymouth, US.
Which VCs invest in companies like Urotronic?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Urotronic's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Urotronic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.